Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $160,000 | 2 | 78.4% |
| Consulting Fee | $29,542 | 7 | 14.5% |
| Honoraria | $12,000 | 3 | 5.9% |
| Travel and Lodging | $2,277 | 4 | 1.1% |
| Food and Beverage | $190.97 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $184,251 | 11 | $0 (2024) |
| EISAI INC. | $10,550 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $3,987 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $3,222 | 2 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $2,000 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80,000 | 1 | PFIZER INC. ($80,000) |
| 2023 | $86,722 | 4 | PFIZER INC. ($83,500) |
| 2021 | $5,500 | 2 | PFIZER INC. ($3,500) |
| 2020 | $5,000 | 1 | PFIZER INC. ($5,000) |
| 2019 | $6,180 | 4 | PFIZER INC. ($6,180) |
| 2018 | $16,621 | 3 | EISAI INC. ($10,550) |
| 2017 | $3,987 | 3 | GlaxoSmithKline, LLC. ($3,987) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2024 | PFIZER INC. | — | Grant | Cash or cash equivalent | $80,000.00 | General |
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| 08/02/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 07/31/2023 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| 01/30/2023 | PFIZER INC. | — | Grant | Cash or cash equivalent | $80,000.00 | General |
| 10/11/2021 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| 03/24/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/31/2020 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| 10/26/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $923.00 | General |
| 10/26/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $179.00 | General |
| 02/26/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $78.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2019 | PFIZER INC. | VYNDAQEL (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/31/2018 | EISAI INC. | Belviq (Drug) | Consulting Fee | Cash or cash equivalent | $10,550.00 | General |
| Category: Nutrition and Weight Loss | ||||||
| 10/23/2018 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $4,875.00 | General |
| 10/02/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $1,195.76 | General |
| 12/11/2017 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,894.97 | General |
| 12/11/2017 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $80.17 | General |
| 11/10/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $11.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 270 | 283 | $76,791 | $22,084 |
| 2022 | 11 | 402 | 457 | $115,777 | $34,682 |
| 2021 | 9 | 360 | 399 | $97,884 | $31,159 |
| 2020 | 10 | 288 | 332 | $72,259 | $22,749 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 81 | 86 | $34,314 | $10,184 | 29.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 110 | 110 | $21,010 | $5,895 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 47 | $12,643 | $3,472 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $8,032 | $2,301 | 28.6% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 24 | 24 | $792.00 | $232.08 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 85 | 91 | $36,387 | $11,166 | 30.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 142 | 143 | $27,378 | $7,722 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 53 | $10,273 | $3,217 | 31.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $9,148 | $2,867 | 31.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $8,050 | $2,529 | 31.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 28 | $7,794 | $2,437 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 31 | $8,407 | $2,140 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $4,449 | $1,399 | 31.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $2,172 | $681.41 | 31.4% |
| 93356 | Heart muscle strain imaging | Facility | 2022 | 39 | 39 | $1,287 | $389.99 | 30.3% |
| 76376 | 3d radiographic procedure | Facility | 2022 | 16 | 16 | $432.00 | $131.88 | 30.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 66 | 69 | $25,319 | $8,765 | 34.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 131 | 131 | $28,229 | $7,874 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 52 | 57 | $13,713 | $4,920 | 35.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $12,225 | $3,921 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 50 | $9,890 | $3,110 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $4,486 | $1,412 | 31.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 14 | $1,992 | $616.15 | 30.9% |
| 93356 | Heart muscle strain imaging | Facility | 2021 | 29 | 29 | $957.00 | $305.08 | 31.9% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 12 | 12 | $1,073 | $238.09 | 22.2% |
About Dr. Frederick Ruberg, MD
Dr. Frederick Ruberg, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437143070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Ruberg, MD has received a total of $204,010 in payments from pharmaceutical and medical device companies, with $80,000 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Grant" ($160,000).
As a Medicare-enrolled provider, Ruberg has provided services to 1,320 Medicare beneficiaries, totaling 1,471 services with total Medicare billing of $110,675. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Boston, MA
- Active Since 09/09/2005
- Last Updated 12/16/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437143070
Products in Payments
- Belviq (Drug) $10,550
- VYNDAQEL (Drug) $5,078
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M